CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Millions, $ in Millions	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Balance at the beginning of the period (in shares) at Jun. 27, 2020		228.3
Balance at the beginning of the period at Jun. 27, 2020	$ 633.2	$ 0.2	$ 70,146.1	$ (69,347.2)	$ (165.9)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	47.0			47.0
Other comprehensive loss	63.5				63.5
Shares issued under employee stock plans, net of tax (in shares)		2.1
Shares issued under employee stock plans, net of tax	(8.6)		(8.6)
Stock-based compensation	22.3		22.3
Repurchase of common stock (in shares)		(1.9)
Repurchase of common stock	(23.8)			(23.8)
Balance at the end of the period (in shares) at Jan. 02, 2021		228.5
Balance at the end of the period at Jan. 02, 2021	733.6	$ 0.2	70,159.8	(69,324.0)	(102.4)
Balance at the beginning of the period (in shares) at Jun. 27, 2020		228.3
Balance at the beginning of the period at Jun. 27, 2020	633.2	$ 0.2	70,146.1	(69,347.2)	(165.9)
Balance at the end of the period (in shares) at Jul. 03, 2021		228.3
Balance at the end of the period at Jul. 03, 2021	763.9	$ 0.2	70,183.2	(69,322.3)	(97.2)
Balance at the beginning of the period (in shares) at Oct. 03, 2020		229.3
Balance at the beginning of the period at Oct. 03, 2020	681.0	$ 0.2	70,152.5	(69,334.2)	(137.5)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	27.3			27.3
Other comprehensive loss	35.1				35.1
Shares issued under employee stock plans, net of tax (in shares)		0.5
Shares issued under employee stock plans, net of tax	(2.5)		(2.5)
Stock-based compensation	9.8		9.8
Repurchase of common stock (in shares)		(1.3)
Repurchase of common stock	(17.1)			(17.1)
Balance at the end of the period (in shares) at Jan. 02, 2021		228.5
Balance at the end of the period at Jan. 02, 2021	733.6	$ 0.2	70,159.8	(69,324.0)	(102.4)
Balance at the beginning of the period (in shares) at Jul. 03, 2021		228.3
Balance at the beginning of the period at Jul. 03, 2021	763.9	$ 0.2	70,183.2	(69,322.3)	(97.2)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	(20.2)			(20.2)
Other comprehensive loss	(12.1)				(12.1)
Shares issued under employee stock plans, net of tax (in shares)		1.6
Shares issued under employee stock plans, net of tax	(7.2)		(7.2)
Stock-based compensation	26.6		26.6
Repurchase of common stock (in shares)		(8.0)
Repurchase of common stock	(127.9)			(127.9)
Convertible note settlement (Note 11)	151.7		151.7
Balance at the end of the period (in shares) at Jan. 01, 2022		232.5
Balance at the end of the period at Jan. 01, 2022	774.8	$ 0.2	70,354.3	(69,470.4)	(109.3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Convertible note settlement (Note 11) (shares)		10.6
Balance at the beginning of the period (in shares) at Oct. 02, 2021		239.7
Balance at the beginning of the period at Oct. 02, 2021	858.6	$ 0.2	70,349.9	(69,385.6)	(105.9)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	34.6			34.6
Other comprehensive loss	(3.4)				(3.4)
Shares issued under employee stock plans, net of tax (in shares)		0.3
Shares issued under employee stock plans, net of tax	(1.4)		(1.4)
Stock-based compensation	13.2		13.2
Repurchase of common stock (in shares)		(7.5)
Repurchase of common stock	(119.4)			(119.4)
Convertible note settlement (Note 11)	(7.4)		(7.4)
Balance at the end of the period (in shares) at Jan. 01, 2022		232.5
Balance at the end of the period at Jan. 01, 2022	$ 774.8	$ 0.2	$ 70,354.3	$ (69,470.4)	$ (109.3)